Corcept Therapeutics Incorporated ( CORT) - Key Metrics

CORT Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $2.43 $0.40 $0.32 $0.29
2026Q1 $1.58 -$0.30 -$0.16 -$0.16
2025Q4 $1.95 $0.23 $0.37 $0.37
2025Q3 $2.01 $0.19 $0.53 $0.53
2025Q2 $1.87 $0.34 $0.42 $0.42

CORT Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 54.34
2026Q1 0% -33.59
2025Q4 0% 37.83
2025Q3 0% 109.36
2025Q2 0% 55.61

CORT Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.34% 0%
2026Q1 -0.40% 0%
2025Q4 1.06% 0%
2025Q3 0.63% 0%
2025Q2 0.57% 0%

CORT

Price: $114.47

52 week price:
28.66
122.21

Earnings Per Share: 0.44 USD

P/E Ratio: 249.55

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 611800

Ebitda: 13.7 million

Market Capitalization: 12.0 billion

Links: